Japan, Jan. 30 -- ICONIC THERAPEUTICS LLC has got intellectual property rights for 'ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND RELATED METHODS.' Other related details are as follows:
Application Number: JP,2023-142243
Category (FI): A61K31/655,A61K31/337,A61K31/675,A61K31/7068,A61K31/4745,A61K31/704,G01N33/574@A,C07K16/28,C07K16/46,C12N15/62@Z,G01N33/575@A,G01N33/57505,G01N33/5751,A61K47/68,G01N33/57515,A61K39/395@L,A61K39/395@C,A61K49/00,A61K45/00,C12N15/13,C07K16/36,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,C12P21/08,A61K39/395@N,A61K39/395@D,A61P35/00,A61P27/02,G01N33/5752,G01N33/57525,G01N33/5753,A61P9/10,A61P29/00,A61P43/00,121,G01N33/5754,G01N33/57545,G01N33/5755,G01N33/57555,A61K31/282
Stage: Grant (IP righ...